NO2437762T3 - - Google Patents

Info

Publication number
NO2437762T3
NO2437762T3 NO10724631A NO10724631A NO2437762T3 NO 2437762 T3 NO2437762 T3 NO 2437762T3 NO 10724631 A NO10724631 A NO 10724631A NO 10724631 A NO10724631 A NO 10724631A NO 2437762 T3 NO2437762 T3 NO 2437762T3
Authority
NO
Norway
Application number
NO10724631A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42312750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2437762(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2437762T3 publication Critical patent/NO2437762T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
NO10724631A 2009-06-05 2010-06-03 NO2437762T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18433909P 2009-06-05 2009-06-05
PCT/US2010/037153 WO2010141648A2 (en) 2009-06-05 2010-06-03 Artificial tears and therapeutic uses

Publications (1)

Publication Number Publication Date
NO2437762T3 true NO2437762T3 (cg-RX-API-DMAC10.html) 2018-01-06

Family

ID=42312750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10724631A NO2437762T3 (cg-RX-API-DMAC10.html) 2009-06-05 2010-06-03

Country Status (24)

Country Link
US (7) US8496976B2 (cg-RX-API-DMAC10.html)
EP (1) EP2437762B1 (cg-RX-API-DMAC10.html)
KR (1) KR101778316B1 (cg-RX-API-DMAC10.html)
CN (2) CN102458430A (cg-RX-API-DMAC10.html)
AU (1) AU2010256652B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI1011710B8 (cg-RX-API-DMAC10.html)
CA (1) CA2764802A1 (cg-RX-API-DMAC10.html)
DK (1) DK2437762T3 (cg-RX-API-DMAC10.html)
ES (1) ES2646338T3 (cg-RX-API-DMAC10.html)
HK (1) HK1214943A1 (cg-RX-API-DMAC10.html)
HR (1) HRP20171691T1 (cg-RX-API-DMAC10.html)
HU (1) HUE034213T2 (cg-RX-API-DMAC10.html)
IL (1) IL216800A (cg-RX-API-DMAC10.html)
LT (1) LT2437762T (cg-RX-API-DMAC10.html)
MX (2) MX2011013007A (cg-RX-API-DMAC10.html)
MY (1) MY172185A (cg-RX-API-DMAC10.html)
NO (1) NO2437762T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ596932A (cg-RX-API-DMAC10.html)
PL (1) PL2437762T3 (cg-RX-API-DMAC10.html)
PT (1) PT2437762T (cg-RX-API-DMAC10.html)
RU (1) RU2589837C2 (cg-RX-API-DMAC10.html)
SI (1) SI2437762T1 (cg-RX-API-DMAC10.html)
WO (1) WO2010141648A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201108979B (cg-RX-API-DMAC10.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
NO2437762T3 (cg-RX-API-DMAC10.html) 2009-06-05 2018-01-06
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
PL2787968T3 (pl) * 2011-12-07 2020-08-24 Allergan, Inc. Wydajne dostarczanie lipidów do ludzkiego filmu łzowego z użyciem wrażliwego na sól układu emulsyjnego
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
US10085960B2 (en) 2012-03-30 2018-10-02 Brien Holden Vision Institute Methods and compositions for reducing ocular discomfort
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
SG11201704010UA (en) 2014-08-20 2017-06-29 Silk Tech Ltd Fibroin-derived protein composition
KR102487299B1 (ko) * 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
EP3362096B1 (en) 2015-10-14 2023-12-13 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
SG11201808804TA (en) 2016-04-08 2018-11-29 Univ Cornell A method to enhance wound healing using silk-derived protein
US11478437B2 (en) 2016-07-05 2022-10-25 Jenivision Inc. Formulations for hair growth
DK3266446T3 (en) 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride
CA3033507A1 (en) 2016-08-12 2018-02-15 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
CA3032695C (en) * 2016-08-19 2021-11-23 Akrivista, LLC Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
CN110996964A (zh) * 2017-06-30 2020-04-10 杰尼视界公司 用于毛发生长的制剂
BR112020003276A2 (pt) 2017-08-18 2020-09-01 Akrivista, LLC métodos de diagnóstico e tratamento da síndrome do olho seco e composições para tratamento de um olho humano
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
CN115671090A (zh) 2018-07-27 2023-02-03 强生外科视力公司 用于治疗眼睛的组合物和方法
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
CA3106898A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2020021481A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
KR20210009947A (ko) 2019-07-18 2021-01-27 윤영선 산소가 도입된 점안제, 및 그 제조방법
EP3824895A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
EP3824877A1 (en) 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
EP4059508A1 (en) 2021-03-19 2022-09-21 Johnson & Johnson Consumer Inc. Methods of using compositions comprising an iceland moss extract

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104814A (en) * 1980-01-25 1981-08-20 Kunihiro Okanoe Preparation of eye drop
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
WO1989001772A1 (en) 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
CH679210A5 (cg-RX-API-DMAC10.html) * 1988-10-26 1992-01-15 Sandoz Ag
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
AU1172097A (en) 1995-12-27 1997-07-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
GB0012597D0 (en) 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
US7027446B2 (en) 2001-07-18 2006-04-11 P-Cube Ltd. Method and apparatus for set intersection rule matching
JP4284491B2 (ja) 2002-07-16 2009-06-24 豊和工業株式会社 ピストン外形の加工データ生成装置
TWI335819B (en) * 2002-12-24 2011-01-11 Alcon Inc Use of oculosurface selective glucocorticoid in the treatment of dry eye
KR20120066688A (ko) * 2003-02-24 2012-06-22 파마슈티칼 프로덕션스, 인크. 경점막 약물 전달 시스템
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
AU2005262392A1 (en) 2004-07-01 2006-01-19 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating eye disorders and conditions
MX2007002400A (es) * 2004-08-27 2007-05-04 Senju Pharma Co Liquido para lavado de ojos para terapia de ojos secos.
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008027341A2 (en) * 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
US20080312194A1 (en) * 2007-02-28 2008-12-18 Ousler Iii George W Methods and compositions for normalizing meibomian gland secretions
CN101554369B (zh) * 2008-05-12 2012-07-25 陈亚玲 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法
UA36915U (uk) * 2008-05-28 2008-11-10 Львівський Національний Медичний Університет Ім. Данила Галицького Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами
IT1393419B1 (it) 2009-03-19 2012-04-20 Medivis S R L Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
NO2437762T3 (cg-RX-API-DMAC10.html) 2009-06-05 2018-01-06

Also Published As

Publication number Publication date
ZA201108979B (en) 2012-08-29
IL216800A (en) 2017-03-30
US8679554B2 (en) 2014-03-25
WO2010141648A3 (en) 2011-03-10
KR20120046151A (ko) 2012-05-09
NZ596932A (en) 2014-04-30
US20140141106A1 (en) 2014-05-22
US9821020B2 (en) 2017-11-21
BRPI1011710A8 (pt) 2019-11-05
CA2764802A1 (en) 2010-12-09
BRPI1011710B8 (pt) 2021-05-25
US20250082709A1 (en) 2025-03-13
US20180264063A1 (en) 2018-09-20
CN102458430A (zh) 2012-05-16
MY172185A (en) 2019-11-15
HUE034213T2 (en) 2018-01-29
HK1214943A1 (zh) 2016-08-12
BRPI1011710B1 (pt) 2021-01-26
PT2437762T (pt) 2017-11-14
US20120201910A1 (en) 2012-08-09
ES2646338T3 (es) 2017-12-13
US20240108677A1 (en) 2024-04-04
US20220008496A1 (en) 2022-01-13
HRP20171691T1 (hr) 2017-12-15
BRPI1011710A2 (pt) 2016-03-22
SI2437762T1 (en) 2018-02-28
US20130295206A1 (en) 2013-11-07
LT2437762T (lt) 2017-11-27
CN104906170A (zh) 2015-09-16
EP2437762B1 (en) 2017-08-09
AU2010256652B2 (en) 2015-11-26
RU2011151468A (ru) 2013-07-20
US11045515B2 (en) 2021-06-29
MX358504B (es) 2018-08-21
US8496976B2 (en) 2013-07-30
WO2010141648A2 (en) 2010-12-09
EP2437762A2 (en) 2012-04-11
IL216800A0 (en) 2012-02-29
KR101778316B1 (ko) 2017-09-13
DK2437762T3 (da) 2017-11-20
RU2589837C2 (ru) 2016-07-10
AU2010256652A1 (en) 2012-01-12
PL2437762T3 (pl) 2018-01-31
MX2011013007A (es) 2012-02-28

Similar Documents

Publication Publication Date Title
BRPI0925311A2 (cg-RX-API-DMAC10.html)
BR112012003062A2 (cg-RX-API-DMAC10.html)
BRPI0924307A2 (cg-RX-API-DMAC10.html)
BR112012008267A2 (cg-RX-API-DMAC10.html)
BR112012012396A2 (cg-RX-API-DMAC10.html)
BR112012000665A2 (cg-RX-API-DMAC10.html)
BR122021004633A2 (cg-RX-API-DMAC10.html)
BR112012012487A2 (cg-RX-API-DMAC10.html)
BR112012003080A2 (cg-RX-API-DMAC10.html)
BRPI0924534A2 (cg-RX-API-DMAC10.html)
BR112012003853A2 (cg-RX-API-DMAC10.html)
BR112012009446A2 (cg-RX-API-DMAC10.html)
BR112012009797A2 (cg-RX-API-DMAC10.html)
BR112012009703A2 (cg-RX-API-DMAC10.html)
BR112012001263A2 (cg-RX-API-DMAC10.html)
BR112012010357A2 (cg-RX-API-DMAC10.html)
BR112012014856A2 (cg-RX-API-DMAC10.html)
BR112012000159A2 (cg-RX-API-DMAC10.html)
BR112012002627A2 (cg-RX-API-DMAC10.html)
BR112012005951A2 (cg-RX-API-DMAC10.html)
BR112012007654A2 (cg-RX-API-DMAC10.html)
BR112012007672A2 (cg-RX-API-DMAC10.html)
BR112012007671A2 (cg-RX-API-DMAC10.html)
BR112012000156A2 (cg-RX-API-DMAC10.html)
BRPI0924617A2 (cg-RX-API-DMAC10.html)